Stock Detail
CLARIENT INC
CLRT @ Yahoo Finance | CLRT Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $4.99 | $4.99 | $0.00 | 0.00% | 0.00 | $4.99 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $0.00 | $0.00 | 0 | 442.62M | 339,928 | -83.17 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 8.32 | 6.66 | 3.33 | 1.67 | -1.66 |
Stock Profile
Clarient, Inc. operates as a diagnostic technology and services company. It provides various laboratory services, including in-house pathology testing using its proprietary automated cellular imaging system (ACIS) and other diagnostic technologies that assist physicians in managing cancer. The ACIS combines an automated microscope with computer-based color imaging technology and is used by pathologists and researchers to analyze specimens placed on slides and stained with color-producing, commercially available reagents. Clarient also develops ACIS-based tools for academic and biopharmaceutical company researchers. The company was founded in 1993. It was formerly known as ChromaVision Medical Systems, Inc. and changed its name to Clarient, Inc. in March 2005. The company is headquartered in San Juan Capistrano, California. Clarient, Inc. is a majority owned subsidiary of Safeguard Scientifics, Inc., as of March 15, 2005.